REVIEW AND NOTIFICATION
Abstract submissions are no longer being accepted for this conference. The abstract submission deadline was Monday, August 12. Only those abstracts that have been reviewed and selected by the Scientific Committee may be presented. All individuals listed as ABSTRACT PRESENTERS will be notified of acceptance or rejection by email approximately 3-4 weeks after the abstract submission deadline. Notices and instructions will be sent to the email address provided at the time of abstract submission. If an abstract is not selected for presentation, the presenter may request a full refund of the registration fee by contacting the AACR Meetings Department at email@example.com.
For those abstracts that are accepted for poster presentation, poster boards will be 4 feet high and 8 feet across (1.22m x 2.44m) and the AACR will provide poster numbers and pushpins. See a sample poster layout. For programs that include short talks selected from the abstract submissions, instructions will be sent to the ABSTRACT PRESENTERS with the date, time and format for those presentations.
PUBLICATION OF ABSTRACTS
The Online Itinerary Planner is now available for the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Supported by a generous contribution from Novartis Oncology, the Itinerary Planner enables you to search or browse sessions, presenters, and abstracts and to select results to create a personal schedule for the conference.
Please Note: Due to the sensitive nature of the data in the abstracts for this conference, authors were given the option to have their abstract body embargoed until the first day of the conference. Therefore, some abstract bodies have been withheld and will be posted on Saturday, October 19, 2013. In addition, a small number of abstracts that have been selected for press coverage will be made available at the time of their presentation. The abstracts will also be published as an online-only supplement to the AACR journal Molecular Cancer Therapeutics after the conference.
REGISTRATION AND ACCOMMODATIONS
Individuals planning on presenting an abstract at this conference are encouraged to register and make a room reservation at the conference hotel as early as possible. If an abstract is not accepted for presentation at the conference, the presenter may request a full refund of the registration fee and may cancel his/her room reservation at no charge up to 24 hours before the scheduled arrival date. For additional information, please visit the registration and accommodations and travel webpages.
REQUEST FOR WITHDRAWAL
Once an abstract has been submitted, it may be withdrawn only by written request from the ABSTRACT PRESENTER. The request may be sent by fax to (215) 599-0111 or email to firstname.lastname@example.org and must be received at least 30 days prior to the start of the conference.
DISCLOSURE OF CHEMICAL STRUCTURES
At the time of abstract submission, the submitting author was required to state whether chemical compounds were used in the scientific work to generate the data in the abstract. Chemical compounds are defined as low-molecular-weight (generally <1000 g/mol) organic or inorganic molecules, peptides, or proteins/nucleic acids co-crystallized with low molecular-weight molecules. If chemical compounds were used, the corresponding author was further required to indicate whether the complete chemical structures of the compounds used will be disclosed at the time of presentation at the conference. The chemical structures were not required to be included at the time of abstract submission; rather, an indication of the intent to disclose any such structures at the time of presentation was required. The Scientific Committee will then evaluate the information provided by the corresponding author and determine the acceptability of the proffered paper for presentation. Those who do not intend to disclose chemical structures may have their abstracts rejected for participation; however, a limited number of these abstracts may be accepted for presentation if deemed to be of sufficient scientific merit.